Logo image of CDEV

CENTENNIAL RESOURCE DEVELO-A (CDEV) Stock Fundamental Analysis

NASDAQ:CDEV - Nasdaq - US15136A1025 - Common Stock - Currency: USD

7.62  -0.61 (-7.41%)

After market: 7.7 +0.08 (+1.05%)

Fundamental Rating

4

CDEV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. CDEV may be in some trouble as it scores bad on both profitability and health. CDEV is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CDEV was profitable.
CDEV Yearly Net Income VS EBIT VS OCF VS FCFCDEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 500M -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA 9.6%
ROE 13.66%
ROIC 14.28%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CDEV Yearly ROA, ROE, ROICCDEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -10 -20

1.3 Margins

Industry RankSector Rank
OM 49.58%
PM (TTM) 28.46%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CDEV Yearly Profit, Operating, Gross MarginsCDEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

CDEV has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CDEV has been increased compared to 1 year ago.
The debt/assets ratio for CDEV has been reduced compared to a year ago.
CDEV Yearly Shares OutstandingCDEV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M
CDEV Yearly Total Debt VS Total AssetsCDEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B

2.2 Solvency

CDEV has an Altman-Z score of 1.93. This is not the best score and indicates that CDEV is in the grey zone with still only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.27 indicates that CDEV is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 1.93
ROIC/WACC1.21
WACC11.84%
CDEV Yearly LT Debt VS Equity VS FCFCDEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 1B -1B 2B 3B

2.3 Liquidity

CDEV has a Current Ratio of 1.11. This is a normal value and indicates that CDEV is financially healthy and should not expect problems in meeting its short term obligations.
CDEV has a Quick Ratio of 1.11. This is a normal value and indicates that CDEV is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
CDEV Yearly Current Assets VS Current LiabilitesCDEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 277.78% over the past year.
The Earnings Per Share has been growing by 9.70% on average over the past years. This is quite good.
The Revenue has grown by 97.30% in the past year. This is a very strong growth!
CDEV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 59.80% yearly.
EPS 1Y (TTM)277.78%
EPS 3Y-18.99%
EPS 5Y9.7%
EPS Q2Q%766.67%
Revenue 1Y (TTM)97.3%
Revenue growth 3Y4.95%
Revenue growth 5Y59.8%
Sales Q2Q%103.22%

3.2 Future

CDEV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.25% yearly.
CDEV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.84% yearly.
EPS Next Y366.63%
EPS Next 2Y137.1%
EPS Next 3Y74.57%
EPS Next 5Y43.25%
Revenue Next Year109.59%
Revenue Next 2Y84.39%
Revenue Next 3Y49.42%
Revenue Next 5Y40.84%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CDEV Yearly Revenue VS EstimatesCDEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B
CDEV Yearly EPS VS EstimatesCDEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.95, the valuation of CDEV can be described as very cheap.
CDEV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.31.
With a Price/Forward Earnings ratio of 3.23, the valuation of CDEV can be described as very cheap.
The average S&P500 Price/Forward Earnings ratio is at 22.13. CDEV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.95
Fwd PE 3.23
CDEV Price Earnings VS Forward Price EarningsCDEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.74
CDEV Per share dataCDEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CDEV's earnings are expected to grow with 74.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.02
PEG (5Y)0.61
EPS Next 2Y137.1%
EPS Next 3Y74.57%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CDEV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTENNIAL RESOURCE DEVELO-A

NASDAQ:CDEV (9/1/2022, 8:00:02 PM)

After market: 7.7 +0.08 (+1.05%)

7.62

-0.61 (-7.41%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-03 2022-08-03/amc
Earnings (Next)11-01 2022-11-01
Inst Owners0%
Inst Owner Change0%
Ins Owners1.57%
Ins Owner Change0%
Market Cap2.17B
Analysts75.29
Price Target10.4 (36.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.95
Fwd PE 3.23
P/S 1.52
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB N/A
EV/EBITDA 2.74
EPS(TTM)1.28
EY16.8%
EPS(NY)2.36
Fwd EY30.98%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5
BVpS10.42
TBVpSN/A
PEG (NY)0.02
PEG (5Y)0.61
Profitability
Industry RankSector Rank
ROA 9.6%
ROE 13.66%
ROCE N/A
ROIC 14.28%
ROICexc N/A
ROICexgc 14.28%
OM 49.58%
PM (TTM) 28.46%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z 1.93
F-Score8
WACC11.84%
ROIC/WACC1.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)277.78%
EPS 3Y-18.99%
EPS 5Y9.7%
EPS Q2Q%766.67%
EPS Next Y366.63%
EPS Next 2Y137.1%
EPS Next 3Y74.57%
EPS Next 5Y43.25%
Revenue 1Y (TTM)97.3%
Revenue growth 3Y4.95%
Revenue growth 5Y59.8%
Sales Q2Q%103.22%
Revenue Next Year109.59%
Revenue Next 2Y84.39%
Revenue Next 3Y49.42%
Revenue Next 5Y40.84%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A